SPD Swiss Precision Diagnostic GmbH, DCC Plc., Procter & Gamble, Abbott Laboratories, Alere Inc., Quidel Corporation

SEATTLE, May 05, 2021, (PHARMIWEB) —

Overview:

To prove birth, pregnancy fast test kits are used. Fertility fast test kits can help women determine the precise day of ovulation or validate the presence of menopause, although they can also be used to detect sperm count in men.

Statistics

The global fertility and pregnancy rapid test kits market is forecast to hit US$ 1,653.5 million by the end of 2027, from a valuation of US$ 1,217.5 million in 2019.

Drivers:

During the forecast period, the global fertility and pregnancy rapid test kits market is expected to benefit from rising first-time pregnancy rates. As per the National Health Statistics Reports, released in July 2018, the mean age at first birth for women who had ever had a child in the U.S. was 23.1 in 2011–2015, and 20% of married women had their first child at age 30 or older than those who were not married.

To learn more about this report, request a sample copy*

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, and Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/3456

Opportunities:

When researchers found the radioimmunoassay that could detect hCG in urine, the e.p.t Paternity Test was introduced in the U.S. over four decades ago. Next-generation fast testing based on lateral flow immuno assays were introduced to the market in 2003. Present pregnancy and fertility rapid testing, on the other hand, use the same equipment, which has to be changed to prevent false positive and false negative test outcomes.

Restraints:

The global fertility and pregnancy rapid test kits market is projected to be hampered by device-related problems and controversies. Physicians often prefer laboratory experiments to home study and advise patients to do the same. Furthermore, the unreliability of outcomes, such as false negative and false positive results, deters people from using home pregnancy tests to any degree. Non-adherence to device instructions, unclear time window for test and system problems such as insensitivity or hook effect are some of the causes of achieving misleading or inaccurate data.

Key Takeaways:

The pregnancy rapid tests segment of the global fertility and pregnancy rapid test market was worth US$ 678.1 million in 2018, and is projected to grow at a CAGR of 4.3 percent to US$ 951.4 million by 2027. During the forecast period, the segment is projected to rise due to an increase in the number of adolescent pregnancies. As per the WHO (World Health Organization), the unprecedented 21 million girls aged 15 to 19 years in developed countries will become pregnant next year in 2019.

Pregnancy research for human chorionic gonadotropin (hCG). Urine is easy relative to other examinations, and women can safely screen for pregnancy themselves using test kits and a urine sample. Pregnant women have elevated hCG levels in their urine, which can be quickly detected using pregnancy tests. During the forecast period, these trends are expected to sustain growth of the global fertility and pregnancy rapid test kits market.

Key suppliers are present in the North America market, offering their products to the region’s future consumer base. During the forecast period, factors including product releases are expected to help the region expand.

Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/3456

Market Trends:

Mid-stream devices are becoming more common than strips and cassettes on the market. Due to the simplicity and flexibility of use, women prefer mid-stream machines over strips and cassettes. Most consumers dislike cassettes because they are difficult to use with droppers to accurately apply a precise amount of sample to the sample well.

Physicians also advise women on fertility care or contraceptive counselling to use home fertility and pregnancy monitoring kits to confirm levels of reproductive hormones including luteinizing hormone and oestrogen. Women are more likely to repeat experiments in order to affirm the findings.

Digital sensors are increasingly replacing traditional line indicator devices and strips for fertility and pregnancy tests, due to the difficulties of interpreting test outcomes with line indicator devices.

Competitive Landscape

Key companies contributing in the global fertility and pregnancy rapid test kits market are DCC Plc., Alere Inc., bioMérieux SA, Geratherm Medical AG, SPD Swiss Precision Diagnostic GmbH, Prestige Brands Holdings, Inc., Abbott Laboratories, Church & Dwight Co., Inc., Quidel Corporation, and Procter & Gamble.

Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/3456

Detailed Segmentation

By Product Type:

• • Pregnancy Rapid Tests
    • Line-Indicator Devices
      • Strips/Dip Sticks
      • Mid-Stream
      • Cassettes
    • Digital
  • Fertility Rapid Tests
    • Line-Indicator
    • Digital

By Test Type:

• • LH Urine
  • FSH Urine
  • hCG Blood
  • hCG Urine

By Distribution Channel:

• • Hospital Channel
  • Retail Channel
  • Online Channel

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/fertility-and-pregnancy-rapid-test-kits-market-2805

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US:

Mr. Shah

Coherent Market Insights,

1001 4th Ave,

#3200 Seattle, WA 98154, U.S.

Phone: US +1-206-701-6702/UK +44-020 8133 4027

Email: sales@coherentmarketinsights.com